Huang Chang-ming, Lu Hui-shan, Li Ping, Xie Jian-wei, Lin Bi-juan, Zhang Xiang-fu
Department of Oncology, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Sep;11(5):432-5.
To investigate the prognostic factors of surgical treatment for the cancer of stomach fundus and cardia with invasion to body and tail of the pancreas.
A total of 135 patients with cancer of stomach fundus and cardia invading body and tail of the pancreas undergone surgical treatment were enrolled in this study. Twenty of them underwent laparotomy, while 115 underwent gastrectomy with pancreaticosplenectomy, even combined with the resection of other organs for macroscopic invasion to adjacent organs during surgery. The 3-,5-year survival rates, morbidity of postoperative complications and mortality were followed up. The prognostic factors were evaluated by univariate and multivariate analyses.
The median survival time of the patients undergone laparotomy was 4.7 months, of patients treated by gastrectomy combined with pancreaticosplenectomy was 30.5 months,and the difference was significant (chi(2)=403.8, P<0.01). The cumulative 3- and 5-year survival rates of the patients treated by gastrectomy combined with pancreaticosplenectomy were 48.3% and 26.6% respectively. Univariate analysis revealed that significant differences in prognosis of 115 patients undergone combined resection were demonstrated for the following factors: maximal dimension of tumor, macroscopic type, extent of lymph node metastasis according to the Japanese classification, No.10 or No.11 lymph node metastasis,curability and number of invaded organs.And histological depth of invasion, extent of lymph node metastasis according to the Japanese classification, number of invaded organs and curability were significant prognostic factors, examined as variables by multivariate analysis (Cox's proportional hazard model, forward stepwise selection LR method). The postoperative complication rate and mortality of 135 patients were 20.0% and 3.5% respectively.
For cancer located in stomach fundus and cardia with limited invasion to distal pancreas, gastrectomy combined with pancreaticosplenectomy should be performed to improve long-term outcomes. Best long-term survival outcomes would be attained if there are no lymph node metastases, or no incurable factors, or no other organ invasions.
探讨胃底贲门癌侵犯胰体尾手术治疗的预后因素。
本研究纳入135例行手术治疗的胃底贲门癌侵犯胰体尾患者。其中20例行剖腹手术,115例行胃切除联合胰脾切除术,甚至因术中肉眼可见侵犯相邻器官而联合切除其他器官。随访3年、5年生存率、术后并发症发生率及死亡率。通过单因素和多因素分析评估预后因素。
剖腹手术患者的中位生存时间为4.7个月,胃切除联合胰脾切除术患者的中位生存时间为30.5个月,差异有统计学意义(χ²=403.8,P<0.01)。胃切除联合胰脾切除术患者的3年和5年累积生存率分别为48.3%和26.6%。单因素分析显示,115例行联合切除术患者的预后在以下因素方面存在显著差异:肿瘤最大径、大体类型、日本分类法的淋巴结转移范围、第10或11组淋巴结转移、可切除性及侵犯器官数量。多因素分析(Cox比例风险模型,向前逐步选择LR法)将组织学浸润深度、日本分类法的淋巴结转移范围、侵犯器官数量及可切除性作为变量,结果显示这些因素是显著的预后因素。135例患者的术后并发症发生率和死亡率分别为20.0%和3.5%。
对于胃底贲门癌侵犯远端胰腺范围有限者,应行胃切除联合胰脾切除术以改善长期预后。若不存在淋巴结转移、无可切除因素或无其他器官侵犯,则可获得最佳长期生存结果。